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The ability of Toxoplasma gondii to evade the host immune response during primary infection in humans is
poorly understood. In murine toxoplasmosis, infected spleen macrophages release soluble factors that mediate
a transient immunosuppression, which may allow the parasite to become established. When an enriched
population of human monocytes from seronegative individuals was incubated with toxoplasmas in vitro,
soluble factors that mediated marked suppression of mitogen-induced lymphocyte DNA synthesis were re-
leased. Irradiated tachyzoites that do not undergo replication were sufficient stimuli for near-maximal soluble
factor release. Up to 50% of the soluble factor-mediated suppression is attributable to a gamma interferon
(IFN-g)-dependent pathway, and the mediator of the remaining inhibition is neither interleukin-10, trans-
forming growth factor b, prostaglandin E2, lipoxygenase products, nitric oxide, nor tumor necrosis factor
alpha-induced mitochondrial cell-derived reactive oxygen intermediates. IFN-g also mediates the up-regula-
tion of an antigen-presenting cell phenotype by both infected and uninfected macrophages. However, IFN-g
does not activate macrophages to become toxoplasmacidal; instead, intracellular toxoplasmas replicate and
reinfect, eventually lysing the macrophage population. These results suggest that T. gondii is able to evade the
naive host immune response by induction of soluble immunosuppressive factors that allow the parasite to
become established during an acute infection.
Toxoplasma gondii causes a debilitating disease in unborn
children of mothers with primary infection and in the severely
immunosuppressed, especially those suffering from AIDS (17,
27). In general, a primary toxoplasma infection of an immu-
nocompetent host is asymptomatic. During acute, primary in-
fection, the host immune system does not eradicate the para-
site and the parasite disseminates, mainly to the muscle and
brain, remaining latent for the life of the host or until the host
is severely immunosuppressed. Little is known, for human in-
fections, about the mechanism by which toxoplasmas initially
evade the immune response of a naive host to become estab-
lished. In mice, acute toxoplasmosis causes nonspecific immu-
nosuppression of the proliferative response of spleen cells to
mitogens (3, 23, 25, 37) and of the antibody response to specific
and nonspecific antigens (19). Macrophages have been impli-
cated in this immunosuppression (6, 38), and recent studies
have shown a role for interleukin-10 (IL-10) and macrophage-
derived nitric oxide (6, 16, 22). Immunosuppression of mito-
gen-induced spleen cell proliferation was maximal on day 7
postinfection, and the response returned to normal by day 21
(6, 16). To characterize further the ability of T. gondii to sup-
press and hence evade the immune response in humans, an
enriched population of human monocytes was incubated with
T. gondii and the effect on mitogen-stimulated lymphocyte
DNA synthesis was determined in vitro. We report that incu-
bation of enriched human monocytes with T. gondii tachyzoites
results in release of soluble factors (SF) that markedly inhibit
mitogen-induced DNA synthesis by lymphocytes. An impor-
tant component of this SF-mediated down-regulatory response
appears to be gamma interferon (IFN-g). We suggest that
production of SF following tachyzoite infection may result in a
transient general immunosuppression of the host immune sys-
tem, enabling the parasite to establish itself during an acute
infection.
MATERIALS AND METHODS
Reagents. RPMI 1640 was obtained from JRH Biosciences, Lenexa, Kans.
Endotoxin-low fetal bovine serum (FBS) (0.5 EU/ml) was from HyClone Labo-
ratories, Inc., Logan, Utah. Minimal essential medium (alpha modification),
antibiotic-antimycotic solution, Versene buffer, and N-2-hydroxyethylpiperazine-
N9-2-ethanesulfonic acid (HEPES) were supplied by Gibco Laboratories, Grand
Island, N.Y. Ficoll-Hypaque was from Winthrop Laboratories, New York, N.Y.
Butylated hydroxyanisole, concanavalin A, N-iminoethyl-L-ornithine, indometh-
acin, nordihydroguiaretic acid, propidium iodide, rotenone, and thenoyltriflu-
oroacetone were obtained from Sigma Chemical Co., St. Louis, Mo. Gentamicin
sulfate was from United States Biochemical Corp., Cleveland, Ohio. N-Mono-
methylarginine was from Calbiochem, La Jolla, Calif. Paraformaldehyde was
from Eastman Kodak Co., Rochester, N.Y. Phytohemagglutinin P was obtained
from Pharmacia Biotech Inc., Piscataway, N.J. [3H]thymidine was supplied by
Amersham Corp., Arlington Heights, Ill. DIFF-QUIK was from Baxter Health-
care Corp., Miami, Fla. VECTASHIELD was supplied by Vector Laboratories,
Inc., Burlingame, Calif. A TiterZyme prostaglandin E2 (PGE2) enzyme immu-
noassay kit (sensitivity, 1.5 pg/ml) was provided by PerSeptive Diagnostics, Cam-
bridge, Mass. EASIA kits for human IFN-g (sensitivity, 0.03 IU/ml) and human
IL-10 (sensitivity, 1 pg/ml) were supplied by INCSTAR Corp., Stillwater, Minn.
Antibodies. Rabbit anti-SAG-1 immunoglobulin G (IgG) and fluorescein iso-
thiocyanate (FITC)-conjugated rabbit anti-SAG-1 IgG were made and purified
in our laboratory. Anti-human IL-10 (monoclonal antibody [MAb] 19F1) was
graciously provided by J. Abrams, DNAX, Palo Alto, Calif. Anti-human IL-10
neutralizing MAb was obtained from R&D Systems, Minneapolis, Minn. Anti-
transforming growth factor b1 [TGF-b1], -b2, -b3 MAb was from Genzyme,
Cambridge, Mass. Anti-human IFN-g antiserum was graciously provided by H.
M. Shepard, Genentech, Inc., South San Francisco, Calif.
Mouse anti-human monocyte receptor MAbs included those to CD16
(FcgRIII, MAb 3G8), CD32 (FcgRII, MAb IV.3), and CD64 (FcgRI, MAb 32),
all graciously provided by Medarex, Inc., Annandale, N.J.; and to CD11a
(LFA-1, MAb TS 1/22.1.1.13.3; hybridoma obtained from American Type Cul-
ture Collection [ATCC], Rockville, Md.), CD11b (CR3, MAb OKM1; hybrid-
oma obtained from ATCC), CD11c (p150,95, MAb L29; graciously provided by
L. Lanier), CD14 (MAb AML-2-23; graciously provided by M. Fanger), CD18
(b2 integrin subunit, MAb TS 1/18.1.2.11; hybridoma obtained from ATCC),
CD29 (b1 integrin subunit, MAb A-1A5; graciously provided by M. Hemler),
CD40 (MAb G28-5; graciously provided by R. Noelle), CD54 (ICAM-1; ob-
tained from the Developmental Studies Hybridoma Bank), CD58 (LFA-3, MAb
TS 2/9.1.1.4; hybridoma obtained from ATCC), CD85 (B70 [B7/2]; PharMingen,
San Diego, Calif.), b2-microglobulin (MAb BBM1; hybridoma obtained from
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ATCC), and HLA-DR, -DP, and -DQ (MAb IVA12; hybridoma obtained from
ATCC). MAb P3 (graciously provided by M. Fanger) was used as a negative
control. FITC-conjugated F(ab9)2 fragments of affinity-isolated anti-mouse IgG
was provided by Caltag Laboratories Inc., South San Francisco, Calif.
Monocytes and lymphocytes. Cells were obtained by cytophoresis of healthy
volunteers. Mononuclear cells were separated from whole blood with Ficoll-
Hypaque, and monocytes were enriched to 80 to 90% by aggregation at 48C (15).
Platelets were removed from monocytes by washing in Versene buffer (0.2 g of
EDTA per liter in phosphate-buffered saline). Monocytes were routinely cul-
tured overnight in RPMI 1640 containing 20 mM HEPES, 50 mg of gentamicin
sulfate per ml, and 10% heat-inactivated endotoxin-low FBS (medium) at 378C
in tissue culture plates (5 3 105 cells in 500 ml for 24-well plates; 0.8 3 105 cells
in 100 ml for 96-well plates) or in Teflon beakers (2 3 106 cells per ml) before
infection. The remaining lymphocytes, enriched more than 90%, were cultured in
medium (5 3 106 cells per ml) at 378C in tissue culture flasks until their use in
assays 48 h later. They were washed twice immediately before use. Cytocentri-
fuge preparations of purified monocytes and lymphocytes were stained with
DIFF-QUIK, and the percentages of lymphocytes, monocytes, and neutrophils/
eosinophils were determined by microscopy. Special care was taken to ensure
lipopolysaccharide-free conditions in all of the experiments.
Parasites. T. gondii tachyzoites were passaged in human fibroblasts maintained
in minimal essential medium containing antibiotic-antimycotic solution and iso-
lated as described previously (21). Briefly, infected fibroblasts were scraped,
forcibly passed through a 27-gauge needle, centrifuged at 50 3 g for 4 min to
remove large host cell debris, and centrifuged at 900 3 g for 10 min to pellet
parasites. The RH strain is a cloned line of parasites that has been regularly
passaged both in vitro and in vivo (31). The Ptg (PLK) strain is derived from the
cloned P strain (Me49) and is regularly passaged in human foreskin fibroblasts.
The PtgA, PtgB, and PtgC strains are mutants derived from the Ptg wild-type
strain after chemical mutagenesis and selection with MAb to the major parasite
surface antigen, SAG-1, as previously described (20).
Toxoplasma pretreatments. In one series of experiments, freshly isolated
tachyzoites were opsonized, irradiated, or heat killed and then added to macs
(see below). Parasites were opsonized for 30 min at room temperature in me-
dium containing 10 mg of rabbit anti-SAG-1 IgG per ml and used without
washing (to prevent parasite aggregation). Parasites in wells of a 24-well plate (2
3 106 parasites in 1 ml of medium per well) were exposed to UV irradiation in
the center of a biological safety hood for 60 s. This treatment allowed active
penetration, but plaques were not formed when parasites were added to cultured
fibroblasts. Parasites were heat killed at 568C for 30 min (heat-killed parasites did
not penetrate host fibroblasts). Parasites were added to macs within 2 h of
isolation from fibroblasts.
Lymphocyte assay. To determine whether tachyzoite infection resulted in
suppression of an immune response, the proliferative response of lymphocytes
was assayed in the presence of macs (enriched monocytes cultured for 24 h or
longer). Macs represent an initial population of 80 to 90% monocytes that
differentiate into monocyte-derived macrophages in culture. Freshly isolated
macs were routinely cultured overnight and then incubated for 24 h either with
medium (control macs) or with tachyzoites (infected macs). Extracellular toxo-
plasmas were not washed off, since macs remained nonadherent throughout each
experiment. It has been our experience and that of others (29) that toxoplasmas
quickly lose their ability to actively penetrate host cells within a few hours and
therefore that internalization of added tachyzoites by active penetration would
be expected to decline precipitously with time in culture. Lymphocytes/antigen-
presenting cells (APCs) (10 3 105 cells for 24-well plates; 2 3 105 cells for
96-well plates) and mitogen (2 mg of phytohemagglutinin P or concanavalin A
per ml) were added to macs. Since naive lymphocytes respond poorly to specific
antigen, the proliferative response of lymphocytes to mitogen was examined. The
concentration of mitogen that induced optimal lymphocyte proliferation was
determined in preliminary experiments. To provide the requisite APCs for this
response, uninfected macs (not to be confused with control macs) were routinely
added to lymphocytes on the day of use to a final concentration of 15%. After a
24-h incubation with mitogen, cultures were pulsed a further 24 h with [3H]thy-
midine (2 mCi per well for 24-well plates; 0.5 mCi per well for 96-well plates).
Cells were harvested on a glass filter with an automated cell harvester, and the
isotope incorporation was measured by liquid scintillation counting. Results from
three replicate cultures are expressed as mean kilocounts per minute 6 standard
deviation. In some experiments, the percent inhibition of lymphocyte DNA
synthesis was calculated by the following equation: Percent inhibition 5 {1 2
[(Dcpm of lymphocytes/APCs incubated with infected macs)/(Dcpm of lympho-
cytes/APCs incubated with control macs)]} 3 100, where Dcpm is the mean cpm
in response to mitogen minus the mean cpm for unstimulated cultures.
To prevent direct cell-to-cell contact during coculture studies, freshly isolated
monocytes (5 3 105 in 100 ml of medium) were incubated overnight in 0.4-mm-
pore-size, 6.5-mm-diameter tissue culture-treated transwell (TW) inserts (Costar
Corp., Cambridge, Mass.) placed in 24-well plates containing 600 ml of medium
beneath each TW. Parasites, or medium, were added to TWs for 24 h, and TW
inserts were transferred to fresh wells containing lymphocytes/APCs before the
addition of mitogen. In this way, the cells in the TW insert do not make contact
with the cells in the well of the tissue culture plate into which the insert is placed,
although the medium is freely diffusible throughout the TW and the well.
Microscopy. Freshly isolated monocytes (5 3 105/500 ml) were incubated
overnight in medium containing 10% FBS in 24-well plates. Under these condi-
tions, the cells remain nonadherent. Parasites were incubated with macs for 2, 24,
or 48 h; then the plates were placed on ice, and FITC-conjugated anti-SAG-1 (10
mg/ml) was added for 20 min. Cytocentrifuge preparations were made (70,000
cells per 500 ml; 700 rpm for 5 min in a Cytospin 3 [Shandon Lipshaw, Pittsburgh,
Pa.]), and slides were fixed with methanol and then incubated for 5 min at room
temperature with 0.5 mg of propidium iodide per ml. An anti-quenching agent
was added, and a coverslip was applied. Preparations were examined at 31,000
magnification in a Zeiss Axiophot microscope equipped for simultaneous obser-
vation of red/green fluorescence. In these preparations, the cell surface of ex-
tracellular parasites stains green and host cell and parasite nuclei (both intra-
cellular and extracellular parasites) stain red.
Adherence versus nonadherence. When 500,000 freshly isolated enriched
monocytes in medium containing 10% FBS were added to a well or to a glass
coverslip in a well, they did not adhere and are referred to as nonadherent macs.
When the same population of macs was resuspended in serum-free medium at a
lower concentration, they became adherent. The largest number of cells that
could be added so that more than 90% remained adherent was 200,000 macs per
12-mm-diameter glass coverslip. Hence, freshly isolated diluted enriched mono-
cytes in serum-free medium were added in a 100-ml drop on top of a 12-mm-
diameter glass coverslip in a well. After a 30-min incubation at 378C, 400 ml of
medium containing 12.5% FBS was added. For nonadherence, freshly isolated
enriched monocytes in 500 ml of medium containing 10% FBS were diluted and
added to wells. After overnight culture, all diluted adherent or nonadherent macs
were infected with 250,000 Ptg strain tachyzoites. At 2 h after infection, cyto-
centrifuge preparations of nonadherent cells were made and counted and cov-
erslips containing adherent cells were washed, fixed, and counted. The same
number of lymphocytes/APCs with or without mitogen were added to different
numbers of either control macs or macs infected for 24 h, and DNA synthesis was
measured 48 h later.
Cytofluorography. Freshly isolated, enriched monocytes were incubated over-
night in medium in Teflon beakers before the addition of tachyzoites (at a
mac/Ptg ratio of 2:1), medium, or IFN-g for 24 h. Macs were stained with MAbs
as described previously (14) and analyzed in a Facscan flow cytometer (Becton
Dickinson, San Jose, Calif.). Briefly, macs were removed from Teflon beakers
after incubation on ice for 20 min and washed, and 2 3 105 macs in 20 ml were
mixed with 20 ml of human IgG (to block nonspecific binding of MAbs to FcgRI)
and 20 ml of MAb for 45 min at 48C. After they were washed, 40 ml of a 1:40
dilution of FITC-conjugated F(ab9)2 fragments of affinity-isolated anti-mouse
IgG (Caltag Laboratories Inc.) was added for a further 45 min at 48C. Cells were
washed and fixed overnight in 1% paraformaldehyde. CD14-positive cells were
gated, and data were acquired with LYSYS software (Becton Dickinson) and
analyzed with Cell-Quest software (Becton Dickinson).
Statistics. Statistics for cpm data were analyzed by either one- or two-way
analysis of variance (ANOVA) with log-transformed data (10).
RESULTS
Contact between T. gondii and enriched monocytes triggers
the release of an SF that suppresses mitogen-stimulated lym-
phocyte DNA synthesis. To determine whether infected human
macs can affect mitogen-induced lymphocyte DNA synthesis,
macs (enriched monocytes cultured for 24 h) were incubated
with T. gondii (infected macs) or with medium (control macs)
for 24 h and then added to the lymphocyte assay mixture.
Figure 1 shows a vigorous mitogen-induced lymphocyte re-
sponse in the presence of control macs that was inhibited by
85% in the presence of infected macs (compare a and b).
Lymphocyte DNA synthesis in the absence of mitogen stimu-
lation, perhaps as a result of FBS components in the medium,
was also inhibited in the presence of parasite-treated macs.
Similar inhibition of mitogen-induced lymphocyte DNA syn-
thesis was observed when a 0.4-mm-pore-size TW separated
lymphocytes/APCs from parasites and macs (Fig. 1, compare c
and d), suggesting that an SF that mediates inhibition of mi-
togen-induced lymphocyte DNA synthesis is released by in-
fected macs.
In a parallel assay, contaminating fibroblast debris prepared
in equal concentration and volume did not inhibit the lympho-
cyte response to mitogen (data not shown). Inhibition is not
due to lymphocyte/APC death as a consequence of cell lysis by
parasites, since cell numbers and viability were similar for
mitogen-stimulated lymphocytes/APCs in the presence of con-
trol and infected macs (data not shown) and since a similar
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inhibition of mitogen-induced lymphocyte DNA synthesis was
observed through the transmembrane pore that separated lym-
phocytes/APCs from the parasites and macs.
To determine whether extracellular parasites can release SF,
parasites alone were added to TWs with macs in the wells
beneath. After 24 h, lymphocytes and mitogen were added to
wells and DNA synthesis was determined by thymidine incor-
poration. When parasites were separated from macs by a TW,
there was no inhibition of lymphocyte DNA synthesis (Fig. 1,
compare a and e). A similar result was obtained when the
number of parasites was increased 10-fold (data not shown).
These results suggest that the inhibitory SF is not produced
unless parasites are in contact with macs.
Early phase of SF release from infected macs. To determine
the time required for contact of macs and parasites to result in
maximal inhibition of lymphocyte DNA synthesis, macs and
parasites were incubated together in TWs for various times,
TWs were transferred to wells containing lymphocytes/APCs,
mitogen was added, and DNA synthesis was measured 48 h
later. When parasites were added to macs at the same time as
lymphocytes/APCs and mitogen, there was 40% inhibition of
lymphocyte DNA synthesis (Fig. 2). No further release of SF
occurred for 4 h after infection. The highest rate of SF release
occurred between 4 and 24 h postinfection, and SF release
continued at a lower rate between 24 and 48 h postinfection.
The conditioned medium remaining after removal of the TWs
was also assayed, and no significant release of SF was found
during the 24 h after infection (data not shown). Hence, early
release of SF from infected macs peaks between 4 and 24 h
after contact of parasites with macs.
Live, nonreplicating parasites are sufficient triggers for SF
release from infected macs. To determine the conditions under
which T. gondii triggers SF release, parasites were treated in
various ways before they were added to macs for 24 h. Mito-
gen-induced lymphocyte DNA synthesis was determined in the
presence of control and infected macs, and infection of macs in
the absence of mitogen and added lymphocytes/APCs was
monitored microscopically over 48 h. No infected lymphocytes
were present in the mac population at any time after infection,
although an occasional infected neutrophil was observed. In-
hibition was similar whether macs were in contact with lym-
phocytes/APCs or separated from them by TWs.
After a 2-h incubation with either untreated, opsonized, or
irradiated tachyzoites (mac/Ptg ratio, 5:1), up to 4% of mac-
rophages became infected while 1% of macrophages internal-
ized heat-killed parasites (Table 1). Digested heat-killed par-
asites did not significantly inhibit lymphocyte DNA synthesis.
Untreated and opsonized parasites were able to replicate, al-
though reinfection was higher for untreated than for opsonized
FIG. 1. Contact between untreated parasites and macs triggers the release of
an SF that suppresses mitogen-induced lymphocyte DNA synthesis. Medium or
Ptg strain tachyzoites at a mac/Ptg ratio of 2:1 were added to macs either in wells
or in TW inserts as shown for 24 h, lymphocytes/APCs were added to each well
without (h) or with (n) mitogen, and lymphocyte DNA synthesis was measured
48 h later. Values are means 6 standard deviations (SD) of triplicate determi-
nations. Results are representative of three donors.
FIG. 2. Maximal inhibition peaks when macs are infected for 4 to 24 h before
being added to the lymphocyte assay mixture. Medium or Ptg strain tachyzoites
at a mac/Ptg ratio of 5:1 were added to macs in TWs for 2, 4, 24, or 48 h. TWs
were transferred to wells containing lymphocytes/APCs, mitogen was added, and
DNA synthesis was measured 48 h later. Values were determined from means 6
SD of triplicate determinations. Results are representative of two donors.
TABLE 1. Response of macs to infection with toxoplasmasa
Parasite
pretreatment
%
inhibitionb
Infection
time (h)
%
of macs
infected
No. of
toxoplasmas
/infected mac
No. of
toxoplasmas
/100 macs
None 98c 2 3 1.4 4
24 8 2.2 16
48 39d 3.4 131
IgG opsonized 100c 2 4 1.2 5
24 6 3.5 20
48 13 2.2 29
Irradiated 71c 2 3 1.2 3
24 4 1.5 6
48 3 1.2 3
Heat killed 15e 2 1 1.8 1
24 0 0 0
48 0 0 0
a Results are representative of two donors.
b Numbers represent percent inhibition of the response measured in the pres-
ence of control macs (157 kcpm). The uptake of lymphocytes cultured in the
absence of mitogen ranged from 14 to 18 kcpm in the presence of control macs
or macs treated with heat-killed or irradiated parasites and was 6 kcpm in the
presence of macs incubated with untreated or opsonized parasites.
c P , 0.001 versus control macs by a two-way ANOVA with log data.
dWithin a further 24 to 48 h of infection, all macs lysed, leaving large numbers
of extracellular parasites.
e Not significantly different from control macs by a two-way ANOVA with log
data (P , 0.4).
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parasites. Near-100% inhibition of lymphocyte DNA synthesis
was observed with either untreated parasites or opsonized par-
asites. However, irradiated parasites that failed to replicate
were sufficient stimuli to result in 71% inhibition of lymphocyte
proliferation as determined by DNA synthesis. These results
suggest that nonreplicating, live parasites are sufficient triggers
for SF release from macs.
SF release is parasite dose dependent. To determine the
relationship between parasite number and immunosuppres-
sion, a constant number of macs in wells was incubated with
increasing numbers of tachyzoites for 24 h before addition to
the lymphocyte assay mixture. As shown in Fig. 3, 90% inhi-
bition was seen with a mac/parasite ratio of 5:1 and 50%
inhibition was achieved with a ratio of 20:1. A similar inhibi-
tory dose-dependent response was seen for T. gondii Ptg and
strains deficient in SAG-1 (PtgA, PtgB, and PtgC), suggesting
that inhibition does not correlate with expression of the major
surface antigen of T. gondii (data not shown).
Nonadherent macs release more SF than adherent macs
when infected with toxoplasmas, and this correlates with par-
asite index. The experiments described so far were performed
with nonadherent macs. This population of cells routinely com-
prised 90% monocyte-derived macrophages, 5% neutrophils,
and 5% lymphocytes (containing 15% NK cells). The relation-
ship between mac number and immunosuppression and the
effect on immunosuppression of adhering the monocytes were
then determined. Diluted nonadherent or adherent macs from
the same population of cells and differing by an adherence step
were cultured overnight, infected with the same number of
tachyzoites for 24 h, and added to the lymphocyte assay mix-
ture. The initial infection of diluted macs in the absence of
mitogen and added lymphocytes/APCs was also determined
microscopically. Since contact between parasites and macs trig-
gers the release of SF, a parasite index was used to estimate the
total interaction.
When adherent macs were diluted, decreasing inhibition
correlated with both decreasing numbers of macs and decreas-
ing parasite index (Table 2). When nonadherent macs were
diluted up to 10-fold, there was no significant change in inhi-
bition, although the parasite index decreased 5-fold (Table 2).
Nonadherent infected macs inhibited the lymphocyte response
to mitogen significantly more than the same number of adher-
ent infected macs did. For example, with 50,000 macs, both
inhibition and parasite index were at least 50% lower for ad-
herent macs than for the same number of nonadherent cells
(Table 2). These results suggest that nonadherent macs are
more permissive to parasite attachment and invasion and
hence are triggered to release more SF than are adherent
macs.
Up-regulation of human macrophage receptors during acute
infection in vitro. Macrophages play a major role in infection
as APCs, presenting antigen together with the appropriate
costimulatory surface molecules. To determine whether SF
may comprise cytokines that may alter the expression of co-
stimulatory or adhesion molecules on human monocytes, macs
were incubated with medium or tachyzoites overnight. As de-
termined by reactivity with anti-receptor antibody and fluores-
cence-activated cell sorter analysis, receptor up-regulation be-
gan 7 h after infection (data not shown). After 24 h of
infection, the time at which SF release has peaked (Fig. 2), a
two- to fivefold increase in ICAM-1, CD40, and FcgRI cell
surface expression was observed for infected macrophages
compared with uninfected macrophages, although either no
change, or less than a 2-fold change, was seen in expression of
B7-2, major histocompatibility complex class II and class I,
CD29, LFA-3, CD18, CD11a, CD11b, CD11c, or FcgRII (Fig.
4 and data not shown). Of note, after 24 h of incubation, with
less than 40% of macrophages infected (three toxoplasmas/
infected macrophage), a unimodal distribution of fluorescence
showed that the entire population of macrophages, both unin-
fected and infected, modulated their cell surface molecules
(e.g., ICAM-1 [Fig. 4]).
IFN-g mediates up-regulation of macrophage receptors as-
sociated with an APC phenotype. The above results indicate
that up-regulation of macrophage cell surface receptors in
response to infection occurs in both the uninfected and in-
fected macrophages of a population of infected cells. This
would suggest that an SF released following infection of host
cells may mediate this response. To determine if IFN-g is
released following infection of macs, receptor modulation of
uninfected, infected, and IFN-g-primed macrophages was
compared in the presence of anti-IFN-g or a control antibody.
Figure 4 shows that up-regulation of the expression of FcgRI,
FIG. 3. Inhibition of lymphocyte DNA synthesis is parasite dose dependent.
Medium or different numbers of untreated RH strain tachyzoites were added to
the same number of macs in wells for 24 h. Lymphocytes/APCs without (h) or
with (n) mitogen were added, and DNA synthesis was measured 48 h later.
Values are means 6 SD of triplicate determinations. Data are representative of
three donors.
TABLE 2. Inhibition correlates with parasite index and is greater
for nonadherent than for adherent macsa
Type of mac No. of macsper well
%
Inhibitionb
Parasite
indexc
Adherent 200,000 78 31,000
150,000 69 14,000
100,000 53 13,000
50,000 37 10,000
Nonadherent 500,000 88 94,000
250,000 92 66,000
100,000 85 30,000
50,000 79 18,000
a Results are representative of two donors.
b Numbers represent the percent inhibition of the response measured in the
presence of control macs (range, 96 to 135 kcpm) and are all statistically signif-
icantly different from those for the respective control macs (P , 0.001 by a
two-way ANOVA with log data). The uptake of [3H]thymidine by lymphocytes
cultured in the absence of mitogen ranged from 7 to 14 kcpm in the presence of
control macs and from 3 to 14 kcpm in the presence of infected macs.
c Parasite index 5 (mean number of parasites/infected mac) 3 percentage of
macs infected 3 total number of macs.
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CD40, B7-2, ICAM-1, and major histocompatibility complex
class II by macrophages after 24 h of incubation with parasites
was ablated in the presence of anti-IFN-g, whereas CD29 and
LFA-3 showed less than a twofold change in expression in the
presence of anti-IFN-g. Similarly, IFN-g treatment of macro-
phages resulted in up-regulation of the same subset of recep-
tors, although at a higher level of expression than occurred
when parasites were used. Again, this increased expression was
FIG. 4. Effect of anti-IFN-g on the up-regulation of macrophage receptors following infection or IFN-g-priming of macs for 24 h. Macs were incubated in Teflon
beakers overnight with medium (Uninfected), T. gondii (Infected; mac/Ptg ratio, 2:1), or IFN-g (IFN-primed; 50 IU/ml) in the presence of normal rabbit serum (light
lines) or rabbit anti-IFN-g serum (heavy lines). Cells were stained with anti-receptor antibodies followed by a FITC-conjugated second antibody, and CD14-positive
cells were examined by flow cytometry. Graphs represent equivalent numbers of cells. Numbers represent the mean fluorescence intensity of staining for each
anti-receptor MAb in the presence of normal rabbit serum or rabbit anti-IFN-g serum. Results are representative of three donors.
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ablated in the presence of anti-IFN-g, with the exception of
ICAM-1, for which the expression was reduced rather than
abrogated. These results suggest that IFN-g is produced during
the 24-h incubation of nonadherent macs with tachyzoites and
that this cytokine mediates up-regulation of a subset of cell
surface receptors on all macrophages, both uninfected and
infected.
Parasites trigger the increased release of IFN-g and PGE2,
but not IL-10. Since IFN-g is produced when macs are incu-
bated with tachyzoites, it is possible that it plays a role in
inhibition of mitogen-induced lymphocyte DNA synthesis (2, 7,
9). To determine whether the kinetics of release of SF and
IFN-g were similar, macs were infected and conditioned me-
dium was removed at various times after infection and assayed
for SF and for IFN-g. The greatest release of SF into condi-
tioned medium occurred between 30 and 54 h after incubation
of host cells with tachyzoites (Fig. 5). Conditioned medium was
also tested by enzyme-linked immunosorbent assay (ELISA)
for IL-10 and PGE2. IL-10 was released in similar small
amounts in conditioned medium from host cells incubated in
either the presence or absence of parasites. However, IFN-g
and PGE2 were released only from host cells incubated with
parasites, with kinetics similar to SF release (Fig. 5).
To determine whether PGE2, lipoxygenase products, nitric
oxide, TGF-b, IL-10, or tumor necrosis factor alpha-induced
mitochondrial cell-derived reactive oxygen intermediates (4,
34) are components of SF, either inhibitors or neutralizing
MAbs were added to macs before the addition of parasites
and, in some experiments, again before the addition of lym-
phocytes and mitogen. Indomethacin and nordihydroguiaretic
acid (both alone and together), N-monomethylarginine, N-
iminoethyl-L-ornithine, the inhibitors of mitochondrial elec-
tron transport (rotenone, butylated hydroxyanisole, and the-
noyltrifluoroacetone), anti-TGF-b, and anti-IL-10 did not alter
the inhibitory response seen when macs were incubated with
parasites (Table 3). Hence, PGE2, lipoxygenase products, ni-
tric oxide, TGF-b, IL-10, and tumor necrosis factor alpha-
induced mitochondrial cell-derived reactive oxygen intermedi-
ates are not components of SF.
FIG. 5. Kinetics of release of SF, IFN-g, and PGE2 from infected macs.
Conditioned medium was removed from macs at each time point and centrifuged
at 900 3 g for 10 min, and the supernatant was added either to the lymphocyte
assay mixture to determine the presence of SF (A) or to ELISA plates to
determine the presence of IFN-g and PGE2 (B). Uninfected macs did not release
measurable IFN-g or PGE2. Values are means 6 SD of triplicate determina-
tions. Data are representative of two donors.
TABLE 3. Summary of the effect of inhibitors and neutralizing MAbs on mitogen-induced lymphocyte DNA synthesis
Addition to lymphocyte assaya Inhibition Final concns
Control macs None
Infected macs Maximal
1 indomethacin Maximal 0.1, 1, 10, and 100 mM
1 NDGAb Maximal 1, 10, and 50 mM
1 NDGA 1 indomethacin Maximal 10 mM each
1 N-monomethylarginine Maximal 0.5, 5, 50, and 500 mM
1 N-iminoethyl-L-ornithine Maximal 10 mm and 1 mM
1 anti-hTGF-b Maximal 1- and 2-fold the NDc for 0.5 ng of total TGF-b per ml
1 anti-hIL-10 (MAb 19F1) Maximal 10, 50, and 100 mg/ml
1 anti-hIL-10 Maximal 1-, 10-, 100-, and 1,000-fold the ND50 of 5 ng of rhIL-10 per ml
1 rotenone Maximal 2.5, 5, 10, 20, and 40 mM
1 butylated hydroxyanisole Maximal 25, 50, 100, 200, and 400 mM
1 thenoyltrifluoroacetone Maximal 25, 50, 100, 200, and 400 mM
1 anti-hIFN-g 50% of maximal ND100
IFN-g None 0.05, 0.5, 5, and 50 IU/ml
54-h conditioned medium 67% of maximal 1:3 dilution
1 anti-hIFN-g 67% of maximal 1:3 dilution
IFN-g-primed macs 40% of maximal 100 IU/ml
a Inhibitors or antibodies were added to macs in wells 60 min before the addition of parasites at a 5:1 mac/Ptg ratio for a further 24 h. The concentration of inhibitors
or antibodies used was not inhibitory to the lymphocyte assay in the presence of control macs.
b NDGA, nordihydroguiaretic acid.
c ND, neutralizing dose.
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Anti-IFN-g partially relieves inhibition of lymphocyte DNA
synthesis by infected macs. To determine whether IFN-g
played a role in mediating inhibition of mitogen-induced lym-
phocyte DNA synthesis, macs were incubated for 24 h with
medium or parasites in the presence of anti-IFN-g or a non-
specific antiserum. Incubation of macs with parasites in the
absence of serum resulted in 69% inhibition of lymphocyte
DNA synthesis. A dose response in which increasing amounts
of antibody correlated with decreasing inhibition of lympho-
cyte DNA synthesis was seen in the presence of anti-IFN-g
antibody (Fig. 6). The presence of a 100% neutralizing dose of
anti-IFN-g antibody (1:500 dilution) resulted in 37% inhibition
of lymphocyte DNA synthesis, a nearly 50% decrease in the
immunosuppression observed in the absence of antibody.
Late phase of SF release from infected macs. Two ap-
proaches were taken to determine whether exogenous IFN-g
directly inhibits mitogen-induced lymphocyte DNA synthesis.
Firstly, lymphocytes/APCs were preincubated with various
doses of IFN-g (50, 5, 0.5, and 0.05 IU/ml) before the addition
of mitogen, or conditioned medium was preincubated with
anti-IFN-g before the addition of lymphocytes/APCs and mi-
togen. No inhibition of thymidine incorporation was observed
for either condition (Table 3). To evaluate whether exogenous
IFN-g may substitute for parasites as a trigger of SF release
from macs, macs were preincubated with increasing amounts
of IFN-g for 24 h before the addition of lymphocytes/APCs
and mitogen. Up to 40% inhibition was observed when IFN-
g-primed macs were added to the lymphocyte assay (Table 3).
These results suggest that exogenous IFN-g alone cannot sub-
stitute for SF but, rather, that IFN-g is a cofactor in the path-
way to production of the SF that directly inhibits the lympho-
cyte response to mitogen. Hence, there is also a late phase to
the inhibitory response, and SFs other than IFN-g play a role
in this phase.
DISCUSSION
We have reported several essential observations that further
our understanding of T. gondii infection in humans. First, we
have demonstrated for the first time that Toxoplasma infection
of a recently derived enriched human monocyte population
results in the production of SF that suppress the host prolif-
erative response to mitogen stimulation. Second, the induction
of this down-regulatory response requires contact between
only a small number of parasites and monocytes. Third, SF
release is at least a two-phase response. Fourth (and paradox-
ically), a principal component of SF is IFN-g, not other factors
more frequently associated with immune down-regulation,
such as IL-10, nitric oxide, and TGF-b.
Our studies suggest that there must be contact between host
cells and parasites for SF release to occur. A single tachyzoite
per 20 macs was sufficient stimulus to mediate 50% inhibition
of lymphocyte DNA synthesis, indicating that tachyzoites are
potent triggers of this response. When live, untreated
tachyzoites were used to infect macs, there was nearly com-
plete inhibition of lymphocyte DNA synthesis. The occurrence
of intracellular replication of tachyzoites suggests that para-
sites entered macs by active penetration rather than by phago-
cytosis. If phagocytosis had occurred, this would have been
followed by endosome fusion and acidification, resulting in
tachyzoite death (8, 18, 29, 36). Hence, maximal SF release
appears to correlate with active penetration. Nearly complete
inhibition of lymphocyte DNA synthesis was also observed for
macs incubated with opsonized parasites, but this maximal SF
release could have been triggered by opsonized parasites that
entered by active penetration rather than by phagocytosis (11).
Hence, antibody opsonization of the parasite did not allow us
to determine whether the mechanism of invasion plays a role in
subsequent SF release. The studies with irradiated or heat-
killed tachyzoites demonstrated that irradiated parasites could
trigger sufficient SF release to mediate 71% inhibition of the
proliferative response despite stasis and parasite degradation.
In contrast, heat-killed parasites that were phagocytosed in
smaller numbers and digested within 24 h failed to trigger
significant SF release from macs, presumably because of heat
denaturation of triggering antigens. Thus, early SF production,
which peaks between 4 and 24 h postinfection (Fig. 2), appears
to be triggered by contact between macs and live but not
heat-killed parasites and is independent of parasite replication.
Hence, products released from macrophages when daughter T.
gondii cells lyse out are unlikely to mediate inhibition of DNA
synthesis by lymphocytes. These conditions that we have de-
scribed, which result in optimal triggering of SF, are similar to
those reported for triggering of IFN-g release from T. gondii-
infected spleen cells from scid mice (35).
When parasites were incubated with adherent rather than
nonadherent macs, there was less inhibition of mitogen-in-
duced lymphocyte DNA synthesis, reflecting less SF release.
The larger the number of parasite-host cell triggering events,
measured as the parasite index, the greater the inhibition, until
maximal inhibition is achieved, and thereafter increasing the
parasite index may simply result in a large excess of released
SF. Since the monocyte-derived macrophages are the only cells
that are infected whether the starting population is adherent or
nonadherent, it is plausible that the pathway leading to SF
release is triggered when parasites interact with these cells. SF
release may be triggered by a specific receptor-ligand interac-
tion between monocyte-derived macrophages and toxoplas-
mas. To date, the only ligand reported to be involved in this
interaction is host-derived laminin, which coats the parasite
(12). Since laminin is part of the host extracellular matrix, it is
unlikely to be a trigger of SF release. The major parasite cell
surface antigen, SAG-1, is also unlikely to trigger SF release,
since incubation of macs with either wild-type strains or mu-
tant strains with deficiencies in SAG-1 resulted in similar im-
munosuppression. Thus, the receptor-ligand interaction that
FIG. 6. Effect of anti-IFN-g on immunosuppression of lymphocyte DNA
synthesis. Rabbit anti-IFN-g serum (n) or normal rabbit serum (u), followed by
medium or Ptg strain tachyzoites at a mac/Ptg ratio of 5:1, were added to macs
in wells for 24 h. Lymphocytes/APCs were added with or without mitogen, and
DNA synthesis was measured 48 h later. Inhibition was determined by using
means 6 SD of triplicate determinations. Results are representative of two
donors. p, statistically significant difference compared with nonspecific serum (P
, 0.001 by a two-way ANOVA with log data).
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occurs during infection of human monocytes and triggers SF
release remains uncertain.
What does SF comprise? A role for cytokines such as IL-10,
which down-regulate B7 or cell-cell adhesion molecules, was
considered. Monocyte-derived macrophages modulated their
cell surface receptors in response to infection with T. gondii
concomitant with peak SF release, but there was an increase in
the expression of a subset of receptors associated with an
antigen-presenting phenotype, a response usually expected as a
prelude to eradicating the pathogen. Accessory and cell-cell
adhesion molecules either remained at constitutive levels or
had increased levels (up to fivefold) in response to infection.
Hence, cytokines such as IL-10, which down-regulate B7 or
cell-cell adhesion molecules, seem unlikely to be components
of the immunosuppressive SF. The up-regulation of monocyte-
derived macrophage cell surface receptors, except ICAM-1,
following incubation of enriched monocytes with parasites was
mediated by IFN-g. A role for IFN-g in immunosuppression of
lymphocyte DNA synthesis has been reported previously for
mice infected with T. gondii (7), Trypanosoma brucei (9), or
Salmonella typhimurium (2). When enriched monocytes were
incubated for 72 h with parasites in the absence of added
lymphocytes and mitogen, a correlation was found between the
kinetics of SF release and the release both of IFN-g and the
eicosanoid, PGE2, suggesting a role for IFN-g and PGE2 as
mediators of this response. Anti-IFN-g neutralized nearly 50%
of the inhibitory effect of SF derived from infected macs, but
PGE2 was excluded as a mediator, since indomethacin had no
effect on the level of inhibition observed. A possible source of
this IFN-g is the residual NK cells in the enriched monocyte
population. Our studies also excluded a role for nitric oxide,
lipoxygenase products, IL-10, TGF-b, and tumor necrosis fac-
tor alpha-induced mitochondrial cell-derived reactive oxygen
intermediates in the inhibition of mitogen-induced lymphocyte
DNA synthesis. Interestingly, IFN-g is unable to prime the
monocyte-derived macrophages for microbicidal activity, since
parasites replicate, reinfect, and eventually lyse the macro-
phage population. Previous studies have shown that tachy-
zoites are susceptible to killing by fresh monocytes (26, 39).
However, these studies used adherent monocytes washed free
of nonadherent cells, whereas our studies used monocytes pu-
rified by a cold aggregation step and cultured under endotoxin-
free, nonadherent conditions. We have previously shown that
nonadherent monocytes are functionally less activated than
their adherent counterparts (11).
When does IFN-g mediate its effect? SF release from in-
fected macs peaked between 4 and 24 h postinfection (Fig. 2).
However, when conditioned medium from infected macs was
added to the lymphocyte assay, it was not inhibitory until
between 30 and 54 h after infection (Fig. 5). These results
suggest that SF release has at least two phases, an early phase
(4 to 24 h postinfection) resulting in the release of a cofactor
that induces the release during a later phase (30 to 50 h
postinfection) of a direct mediator of inhibition. Since anti-
IFN-g was without effect when added to conditioned medium
removed from infected macs 30 to 50 h after infection, at a
time when there was measurable inhibition of lymphocyte
DNA synthesis, IFN-g may be a cofactor involved in the early
response. This conclusion is again suggested by the observation
that IFN-g could prime uninfected macs to become inhibitory
but could not directly inhibit the lymphocyte assay.
There are striking similarities and differences between the
pathways leading to inhibition of mitogen-induced lymphocyte
DNA synthesis either by human macs incubated with toxoplas-
mas in vitro or by infected murine spleen cells taken from
animals infected with toxoplasmas. In both systems, toxoplas-
mas trigger the release of IFN-g (13), which was reported to
mediate completely the inhibitory effect of SF (7). In the mu-
rine system, IFN-g induced the release of nitric oxide, a major
mediator of inhibition of lymphoproliferation (1, 6, 22, 28, 32).
It is still unclear if human monocytes or macrophages produce
nitric oxide (5, 24, 30, 33). Nevertheless, incubation of human
macs with parasites in the presence of nitric oxide synthase
inhibitors did not relieve inhibition of mitogen-induced lym-
phocyte DNA synthesis, suggesting that nitric oxide is not a
component of SF. A role for IL-10 as an inhibitory mediator
was also reported for murine toxoplasmosis (22) but was not
seen for these human studies.
In conclusion, our studies suggest that acute Toxoplasma
infection of human macs triggers the release of a factor(s) that
stimulates the release of IFN-g, which indirectly mediates im-
mune system down-regulation. This down-regulation may be a
host response to reduce immune system-mediated tissue dam-
age, to which the opportunistic parasite has adapted in order to
establish an infection. It is possible that in a natural infection,
once the parasite escapes from the gut of the infected host, it
goes on to infect the nonadherent monocytes in the intestinal
villi. Infected monocytes may transport the tachyzoites to other
sites in the body, e.g., muscle and brain, during the time of
maximal SF release. Hence, the host local immune response
would be transiently suppressed while the tachyzoite infects
tissue cells and transforms into the immunologically cryptic
bradyzoite. In humans, acute Toxoplasma infection can there-
fore result in activation of host innate immunity that both
protects the host against the sequelae of infection and allows
the parasite to persist.
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